Investigations Regarding B-cell Subsets in Humans
Status
Conditions
Treatments
Details and patient eligibility
About
The aim of this research is to define the human equivalent of mouse B1 cells.
Full description
The specific aim of this research project is to define the human equivalent of mouse B1 cells. This will be done by evaluating IgM secretion, surface markers, functional characteristics, V gene usage, N-region addition, and phosphorylation status of intracellular proteins, gene expression, sequencing of immunoglobulin genes, determination of antigenic specificity, replication history, and response to different stimuli.
The goal of this project is to begin to the translation of decades of basic science research and research in the mouse model into the human system. It is believed that properly defining this B cell subset in humans will lead to better therapeutics, prognostics and prevention for a number of disease including infections, autoimmune disease, and cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Subject is considered by the physician to be a healthy adult.
Exclusion criteria
- Subject is under the age of 18
- Subject has an infection or is currently ill
Trial design
249 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal